NaviFUS Corp.
NaviFUS Corp., a medical device company, develops and sells focused ultrasound (FUS) solutions for the unmet needs in neuromedicine in Taiwan. The company develops NaviFUS, a neuronavigator-guided transcranial FUS system that delivers focal energy into deep tissues in the brain, as well as is used in various clinical applications, such as drug delivery, neuromodulation, immuno-stimulation, and ot… Read more
NaviFUS Corp. (6872) - Total Assets
Latest total assets as of September 2025: NT$659.59 Million TWD
Based on the latest financial reports, NaviFUS Corp. (6872) holds total assets worth NT$659.59 Million TWD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
NaviFUS Corp. - Total Assets Trend (2021–2024)
This chart illustrates how NaviFUS Corp.’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
NaviFUS Corp. - Asset Composition Analysis
Current Asset Composition (December 2024)
NaviFUS Corp.'s total assets of NT$659.59 Million consist of 72.2% current assets and 27.8% non-current assets.
| Asset Category | Amount (TWD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | NT$0.00 | 29.8% |
| Accounts Receivable | NT$0.00 | 0.0% |
| Inventory | NT$0.00 | 0.0% |
| Property, Plant & Equipment | NT$0.00 | 0.0% |
| Intangible Assets | NT$0.00 | 0.0% |
| Goodwill | NT$0.00 | 0.0% |
Asset Composition Trend (2021–2024)
This chart illustrates how NaviFUS Corp.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: NaviFUS Corp.'s current assets represent 72.2% of total assets in 2024, a decrease from 94.1% in 2021.
- Cash Position: Cash and equivalents constituted 29.8% of total assets in 2024, down from 52.2% in 2021.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2021.
- Asset Diversification: The largest asset category is goodwill at 0.0% of total assets.
NaviFUS Corp. Competitors by Total Assets
Key competitors of NaviFUS Corp. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
NaviFUS Corp. - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - NaviFUS Corp. generates 0.05x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - NaviFUS Corp. is currently not profitable relative to its asset base.
NaviFUS Corp. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 12.72 | 10.11 | 10.11 |
| Quick Ratio | 12.60 | 10.11 | 10.11 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | NT$445.82 Million | NT$ 380.27 Million | NT$ 380.27 Million |
NaviFUS Corp. - Advanced Valuation Insights
This section examines the relationship between NaviFUS Corp.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.11 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 11.4% |
| Total Assets | NT$546.69 Million |
| Market Capitalization | $5.07K USD |
Valuation Analysis
Below Book Valuation: The market values NaviFUS Corp.'s assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: NaviFUS Corp.'s assets grew by 11.4% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for NaviFUS Corp. (2021–2024)
The table below shows the annual total assets of NaviFUS Corp. from 2021 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | NT$546.69 Million | +11.45% |
| 2023-12-31 | NT$490.54 Million | -6.40% |
| 2022-12-31 | NT$524.07 Million | -11.16% |
| 2021-12-31 | NT$589.92 Million | -- |